Oncolytics Biotech (ONCY) Tops Q1 EPS by 2c

Oncolytics Biotech (NASDAQ: ONCY) reported Q1 EPS of ($0.09), $0.02 better than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Phillip Securities Reiterates Buy Rating on Sea Ltd. (SE)
• Keefe, Bruyette & Woods Downgrades Crescent BDC (CCAP) to Market Perform